Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
07/30/2009 | US20090191602 Methods and Materials for Making Simvastatin and Related Compounds |
07/30/2009 | US20090191592 Glycoengineered, recombinant antibody |
07/30/2009 | US20090191589 Process for producing dipeptides |
07/30/2009 | US20090191586 Enzyme expression methods and compositions |
07/30/2009 | US20090191575 Tumor marker and method for determination of the occurrence of cancerous disease |
07/30/2009 | US20090191560 Mutant dna polymerases and uses therof |
07/30/2009 | US20090191555 HCV NS3-NS4 Protease Resistance Mutants |
07/30/2009 | US20090191552 Novel Human Acidic Mammalian Chitinase and Use Thereof |
07/30/2009 | US20090191206 Human Semen Enhancer of Viral Infection Peptides (SEVI) and Their Use |
07/30/2009 | US20090191199 Glycoengineered, recombinant antibody |
07/30/2009 | US20090191178 Manufacture of Highly Phosphorylated Lysosomal Enzymes and Uses Thereof |
07/30/2009 | US20090191119 Cancerous disease modifying antibodies |
07/30/2009 | CA2713055A1 Selective exosite inhibition of papp-a activity against igfbp-4 |
07/30/2009 | CA2712807A1 Peptides, compositions, and uses thereof |
07/30/2009 | CA2712802A1 Compositions and methods for detecting juvenile renal dysplasia or calcium oxalate stones in dogs |
07/30/2009 | CA2708279A1 Thermal and acid tolerant beta-xylosidases, genes encoding, related organisms, and methods |
07/29/2009 | EP2083089A1 Detection of mutations in a gene associated with resistance to viral infection, oas1 |
07/29/2009 | EP2083084A1 Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells |
07/29/2009 | EP2083074A1 Modified flavine-adenine-dinucleotide-dependent glucose dehydrogenase |
07/29/2009 | EP2083072A1 Stem-regulated, plant defense promotor and uses thereof in tissue-specific expression in monocots |
07/29/2009 | EP2082743A2 Inhibitors of GSK-3 and crystal structures of GSK-3beta protein and protein complexes |
07/29/2009 | EP2082050A2 Delta-8 desaturases and their use in making polyunsaturated fatty acids |
07/29/2009 | EP2082041A2 Novel genes related to glutaminyl cyclase |
07/29/2009 | EP2082034A1 Polysaccharide transferase |
07/29/2009 | EP2082033A2 Activation of the arabidopsis hypertall (hyt1/yucca6) locus affects several auxin mediated responses |
07/29/2009 | EP2082029A2 Metabolically engineered escherichia coli for enchanced production of sialic acid |
07/29/2009 | EP2081594A1 Novel method for treating h.pylori infections |
07/29/2009 | EP1991691A4 Detection of anthrax pathogenicity factors |
07/29/2009 | EP1917361A4 Methods and compositions for expressing negative-sense viral rna in canine cells |
07/29/2009 | EP1689430B1 Tyrosinase mutant and methods of use thereof |
07/29/2009 | EP1572897B1 Ordered biological nanostructures formed from chaperonin polypeptides |
07/29/2009 | EP1484395B1 Transposon being functional in mammals |
07/29/2009 | EP1483282B1 RIBOZYMES WITH BROAD tRNA AMINOACYLATION ACTIVITY |
07/29/2009 | EP1283868B1 Isolated gum operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof |
07/29/2009 | CN101495628A Expression of the cysteine protease legumain in vascular and inflammatory diseases |
07/29/2009 | CN101495627A Extended antegrade epicardial coronary infusion of adeno-associated viral vectors for gene therapy |
07/29/2009 | CN101495626A Identification of a novel type of sucrose synthase and use thereof in fiber modification |
07/29/2009 | CN101495625A Chloramphenicol resistance selection in bacillus licheniformis |
07/29/2009 | CN101492664A Acid protease |
07/29/2009 | CN101492663A Fermentation preparation and extraction method for bacillus subtilis debitterized aminopeptidase |
07/29/2009 | CN101492662A Method for producing human tissue plasmin activator |
07/29/2009 | CN101492661A Clone, expression of beta-glucosidase gene, and preparation for gentian oligose |
07/29/2009 | CN101492660A Plant nuclease, its encoding gene and uses thereof |
07/29/2009 | CN101492659A Enhancement of vanadium-containing phosphatase inhibitors |
07/29/2009 | CN101492658A Plant anthocyanin synthesis of key enzyme-flavanone 3-hydroxylase encoding gene |
07/29/2009 | CN100520793C Method for determination of metabolic flux affecting production of useful material |
07/29/2009 | CN100519755C Fermentation processes and compositions |
07/29/2009 | CN100519753C Recombinant microorganism |
07/29/2009 | CN100519750C An enzyme with endoglucanase activity |
07/29/2009 | CN100519745C Protective agent for increasing stability of alpha-galactosidase prepared by aspergillus ZU-G1 foetidus fermentation and application thereof |
07/29/2009 | CN100519744C Method for improving vitality of lyochrom oxidizing enzyme |
07/29/2009 | CN100519743C New use of G protein coupled acceptor kinase |
07/29/2009 | CN100519729C Improved method for the prevention or reduction of haze in beverages |
07/28/2009 | US7566814 Site-specific recombination in eukaryotes and constructs useful therefor |
07/28/2009 | US7566813 Transgenic soybean seeds exhibiting an oil composition comprising 55 to 80% by weight oleic acid, 10 to 40% by weight linoleic acid, 6% or less by weight linolenic acid, and 2 to 8% by weight saturated fatty acids for use in ehancing applicability in food, biodiesel and biolube markets |
07/28/2009 | US7566774 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
07/28/2009 | US7566694 Anti-pathogen treatments |
07/28/2009 | US7566561 Alpha-amylase mutants |
07/28/2009 | US7566560 Polypeptides and expression vectors host cell and transgenic plants with nucleic acid and stress resistance; antifungal agent |
07/28/2009 | US7566559 Human cyclin-dependent kinase (hPNQALRE) |
07/28/2009 | US7566558 Polyketide synthetase activity; vectors; host cells |
07/28/2009 | US7566557 Genetic engineering; transketolase ; Corynebacterium or Brevibacterium; developed to produce and secrete large amounts of one or more desired fine chemicals |
07/28/2009 | US7566556 Enhancing enzyme thermostability by mixing with sorghum liquor waste |
07/28/2009 | US7566555 Expressing in isolated animal cells a mutant tyrosyl-tRNA synthetase, Bacillus stearothermophilus suppressor tyrosyl tRNA, a gene encoding a desired protein comprising a nonsense mutation at a desired site |
07/28/2009 | US7566553 Transgenic microorganism comprising vector coding oxidoreductase for use as bioreactor in fermentation of lysine for use in medicine, cosmetic and nutraceuticals |
07/28/2009 | US7566529 Method for the recovery of retroviral reverse transcriptase (RT) activity from a sample containing unprotected cellular polymerases |
07/28/2009 | US7566457 Proteins for use as vaccine to prevent dengue virus infection; immunotherapy; high serotype-specificity to be used in humans |
07/28/2009 | US7566455 Vaccine with a component of a ubiquitin-ligase (E3) enzyme; regulation of gene expression, regulation of the cell-cycle, modification of cell surface receptors, biogenesis of ribosomes, and DNA repair |
07/28/2009 | US7566449 Method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and β1 integrins |
07/28/2009 | CA2269088C Method for the production of 1,3-propanediol by recombinant organisms |
07/23/2009 | WO2009091994A2 Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof |
07/23/2009 | WO2009091847A2 Compositions, methods and systems for single molecule sequencing |
07/23/2009 | WO2009091582A1 PRODUCTION OF R-α-LIPOIC ACID BY FERMENTATION USING GENETICALLY ENGINEERED MICROORGANISMS |
07/23/2009 | WO2009091054A1 Novel hydrogen peroxide-forming nadh oxidase, and dna encoding the same |
07/23/2009 | WO2009091053A1 Crystal production method, frozen crystal production method, crystal, crystal structure analysis method, crystallization screening method, and crystallization screening apparatus |
07/23/2009 | WO2009091045A1 Process for production of serine derivative, and protein for use in the process |
07/23/2009 | WO2009090190A1 Mouse models carrying a knock-out mutation of the glutaminyl cyclase gene |
07/23/2009 | WO2009090050A1 Increased production of acetyl coenzyme a |
07/23/2009 | WO2009090004A1 Phosphodiesterase 10 catalytic domain crystals |
07/23/2009 | WO2009089630A1 Cellulase variants with reduced inhibition by glucose |
07/23/2009 | WO2009089620A1 Protein c rs2069915 as a response predictor to survival and administration of activated protein c or protein c-like compound |
07/23/2009 | WO2009073605A3 Drought tolerant plants and related constructs and methods involving genes encoding ferrochelatases |
07/23/2009 | WO2009045536A3 Receptor targeted oligonucleotides |
07/23/2009 | WO2009007091A3 Brassica plant comprising mutant fatty acyl-acp thioesterase alleles |
07/23/2009 | WO2008060695A8 Antiviral inhibition of casein kinase ii |
07/23/2009 | WO2008046943A8 Transposon hsmar2 and use thereof in the generation of vectors that can be used in somatic gene therapy |
07/23/2009 | WO2008003078A8 Short chain volatile hydrocarbon production using genetically engineered microalgae, cyanobacteria or bacteria |
07/23/2009 | WO2008001342A8 Recombinant staphylococcal phage lysin as an antibacterial agent |
07/23/2009 | WO2007123498A8 MUTATED TRUNCATED MT-PFKA GENE FOR THE SYNTHESIS OF ACTIVE SHORTER FRAGMENT OF 6-PHOSPHOFRUCTO-l-KINASE |
07/23/2009 | WO2007087478A8 Linear vectors, host cells and cloning methods |
07/23/2009 | WO2007086738A8 A novel mrna splice variant of the doublecortin-like kinase gene and its use in diagnosis and therapy of cancers of neuroectodermal origin |
07/23/2009 | WO2005056752A9 Methods and compositions for delivering polynucleotides |
07/23/2009 | WO2005042707A9 Taspasel 1 and methods of use |
07/23/2009 | US20090188010 Insect Chymotrypsin and Inhibitors Thereof |
07/23/2009 | US20090188004 Protein Kinase Stress-Related Proteins and Methods of Use in Plants |
07/23/2009 | US20090186906 N-((S)-4,4-dimethyl-1-oxo-1-((3aS,6aR)-3-oxo-dihydro-2H-furo[3,2-b]pyrrol-4(5H6H, 6aH)-yl)pentan-2-yl)-4-(4-methylpiperazin-1-yl)benzamide; treatment of a disease selected from osteoporosis, Paget's disease, Chagas's disease, malaria, gingival diseases, hypercalaemia, metabolic bone disease, bone cancer |
07/23/2009 | US20090186831 Tetrahydrofuro(3,2-B) pyrrol-3-one derivatives as inhibitors of cysteine proteinases |
07/23/2009 | US20090186821 Use of aspartic proteases in cosmetics and therapeutics |
07/23/2009 | US20090186816 Polypeptide targeting to mitochondria |
07/23/2009 | US20090186415 Method for production of cytochrome p450 with n-terminal truncated p450 reductase |